Status:
UNKNOWN
Panic Disorder and Cardiac Risk
Lead Sponsor:
Baker Heart Research Institute
Collaborating Sponsors:
National Health and Medical Research Council, Australia
Conditions:
Panic Disorder
Eligibility:
All Genders
18-65 years
Phase:
NA
Brief Summary
The reason for increased cardiac mortality in panic disorder has not been precisely identified, but possibly is due to chronic activation of the cardiac stimulant (sympathetic) nerves, which may predi...
Eligibility Criteria
Inclusion
- Panic disorder
Exclusion
- Comorbid heart disease
- Comorbid significant psychiatric illness
- Significant suicide risk
- HIV/AIDS hepatitis B/c
Key Trial Info
Start Date :
June 1 2002
Trial Type :
INTERVENTIONAL
End Date :
December 1 2008
Estimated Enrollment :
50 Patients enrolled
Trial Details
Trial ID
NCT00168506
Start Date
June 1 2002
End Date
December 1 2008
Last Update
April 5 2007
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Baker Heart Research Institute
Melbourne, Victoria, Australia, 3121